Clinical Trial Update: Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally [Phase 4]

View source ↗

Summary

Phase 4 trial update on safety and immunogenicity of the inactivated rabies vaccine RABIVAX-S given intramuscularly and intradermally.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabivax-S (rabies vaccine)

Snippet

Sponsor: Vietnam Military Medical University | Conditions: Rabies | Phase 4 | Status: COMPLETED